
[Federal Register Volume 77, Number 63 (Monday, April 2, 2012)]
[Notices]
[Page 19672]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-7756]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-D-0618]


Draft Guidances Relating to the Development of Biosimilar 
Products; Public Hearing; Request for Comments; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public hearing; request for comments; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of March 2, 2012 (77 FR 12853). 
The document announced a public hearing entitled ``Draft Guidances 
Related to the Development of Biosimilar Products; Public Hearing; 
Request for Comments'' to obtain input on recently issued draft 
guidances relating to the development of biosimilar products. The 
document published with an incorrect date for submission of electronic 
and written comments. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Sandra J. Benton, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 51, Rm. 6340, Silver Spring, MD 20993-0002, 301-
796-1042, Fax: 301-847-3529, email: biosimilarspublicmtg@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In FR Doc. 2012-5070, appearing on page 
12853, in the Federal Register of Friday, March 2, 2012, the following 
correction is made:
    On page 12853, in the second column, in the DATES section, the last 
sentence is corrected to read: ``Electronic or written comments will be 
accepted after the public hearing until May 25, 2012.''

    Dated: March 26, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-7756 Filed 3-30-12; 8:45 am]
BILLING CODE 4160-01-P


